symptom burden, medication detriment, and support for the use of the 15d health-related quality of life instrument in a chronic pain clinic population症状负担,药物损害,并支持使用15 d健康相关生活质量的仪器在慢性疼痛诊所人口.pdfVIP

Hindawi Publishing Corporation Pain Research and Treatment Volume 2011, Article ID 809071, 7 pages doi:10.1155/2011/809071 Research Article Symptom Burden, Medication Detriment, and Support for the Use of the 15D Health-Related Quality of Life Instrument in a Chronic Pain Clinic Population Bruce D. Dick,1 Saifudin Rashiq,1 Michelle J. Verrier,1 Arto Ohinmaa,2 and Julie Zhang2 1 Department of Anesthesiology and Pain Medicine, 8-120 Clinical Sciences Building, University of Alberta Edmonton, AB, Canada T6G 2B7 2 School of Public Health, 3-12 University Terrace, University of Alberta, Edmonton, AB, Canada T6G 2T4 Correspondence should be addressed to Bruce D. Dick, bruce.dick@ualberta.ca Received 5 October 2010; Revised 7 January 2011; Accepted 19 January 2011 Academic Editor: Howard S. Smith Copyright © 2011 Bruce D. Dick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Chronic noncancer pain is a prevalent problem associated with poor quality of life. While symptom burden is frequently mentioned in the literature and clinical settings, this research highlights the considerable negative impact of chronic pain on the individual. The 15D, a measure of health-related quality of life (HRQOL), is a user-friendly tool with good psychometric properties. Using a modified edmonton symptom assessment scale (ESAS), we examined whether demographics, medical history, and symptom burden reports from the ESAS would be related statistically to HRQOL measured with the 15D. Symptom burden, medication detriment scores, and number of medical comorbidities were significant negative predictors of 15D scores with ESAS symptom